Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2217/fon-2020-0754 http://scihub22266oqcxt.onion/10.2217/fon-2020-0754 33538178!7874885!33538178     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Future+Oncol 2021 ; 17 (9): 1097-1104 Nephropedia Template TP {{tp|p=33538178|t=2021. The right immune-modulation at the right time: thymosin alpha1 for prevention of severe COVID-19 in cancer patients |pdf=|usr=}}{{33538178}} gab.com Text The right immune-modulation at the right time: thymosin alpha1 for prevention of severe COVID-19 in cancer patients JO: Future Oncol http://www.kidney.de/pget.php?&tw=1&pmid=33538178 #FOAvip We presented the rationale for the use of thymosin alpha1 as prophylaxis of severe COVID-19 in cancer patients undergoing active treatment, constituting the background for the PROTHYMOS study, a prospective, multicenter, open-label, Phase II randomized study, currently in its start-up phase (Eudract no. 2020-006020-13). We aim to offer new hope for this incurable disease, especially to frail patient population, such as patients with cancer. The hypothesis of an effective prophylactic approach to COVID-19 would have immediate clinical relevance, especially given the lack of curative approaches. Moreover, in the 'COVID-19 vaccine race era' both clinical and biological results coming from the PROTHYMOS trials could even support the rationale for future combinatorial approaches, trying to rise vaccine efficacy in frail individuals. Twit Text FOAVip The right immune-modulation at the right time: thymosin alpha1 for prevention of severe COVID-19 in cancer patients ????Future Oncol http://www.kidney.de/pget.php?&tw=1&pmid=33538178 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33538178 #FOAvip English Wikipedia <ref>{{Cite pmid|33538178}}</ref> The right immune-modulation at the right time: thymosin alpha1 for prevention of severe COVID-19 in cancer patients #MMPMID33538178 Bersanelli M; Giannarelli D; Leonetti A; Buti S; Tiseo M; Nouvenne A; Ticinesi A; Meschi T; Procopio G; Danielli R Future Oncol 2021[Mar]; 17 (9): 1097-1104 PMID33538178show ga We presented the rationale for the use of thymosin alpha1 as prophylaxis of severe COVID-19 in cancer patients undergoing active treatment, constituting the background for the PROTHYMOS study, a prospective, multicenter, open-label, Phase II randomized study, currently in its start-up phase (Eudract no. 2020-006020-13). We aim to offer new hope for this incurable disease, especially to frail patient population, such as patients with cancer. The hypothesis of an effective prophylactic approach to COVID-19 would have immediate clinical relevance, especially given the lack of curative approaches. Moreover, in the 'COVID-19 vaccine race era' both clinical and biological results coming from the PROTHYMOS trials could even support the rationale for future combinatorial approaches, trying to rise vaccine efficacy in frail individuals. |*COVID-19 Drug Treatment[MESH] |Adjuvants, Immunologic/therapeutic use[MESH] |COVID-19/*complications[MESH] |Clinical Trials, Phase II as Topic[MESH] |Humans[MESH] |Neoplasms/*complications[MESH] |Randomized Controlled Trials as Topic[MESH] |Research Design[MESH] |SARS-CoV-2[MESH]The right immune-modulation at the right time: thymosin alpha1 for pre(epmc).pdf DeepDyve Pubget Overpricing